Catalent Inc. (CTLT)


Stay up to date

catalyst + talent. our name combines these ideas. from drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success. with over 80 years of experience, we have the deepest expertise, the broadest offerings, and the most innovative technologies to help you get more molecules to market faster, enhance product performance and provide superior, reliable manufacturing and packaging results. catalent develops. with our broad range of expert services we drive faster, more efficient development timelines to help you take more molecules to market and create more effective products. catalent delivers. as the world leader in drug delivery innovations, we have a proven record of enhancing bioavailability, solubility and permeability, improving ease and route of administration, and increasing patient compliance for better treatments. catalent supplies. globally positioned to serve all your manufacturing and commercial packaging needs, we p

Financial Statements

Key Info

  • Industry: Pharmaceutical Preparation Manufacturing
  • Sector: Manufacturing
  • CEO Name: Alessandro Maselli

Key Statistics

  • Stock Price: $56.45
  • Dividend Yield: 0%
  • Market Capitalization: $10,202,641,754
  • Shares Outstanding: 180,737,675
  • Number of Employees: 11,908
  • Trailing 12-Month EPS: $-7.18
  • Trailing 12-Month DPS: $0
  • Payout Ratio: -0.0%

Important Dates

  • Next Earnings Date: 2024-05-01
  • Next Ex-Dividend Date:

Price Trends

  • Current Stock Price: $56.45
  • 52-week high: $67.54
  • 52-week low: $31.45
  • 200-day moving average: $47.09
  • 50-day moving average: $56.97


  • 1-Month Price Return: -2.6%
  • 3-Month Price Return: 25.6%
  • 6-Month Price Return: 24.0%
  • 1-Year Price Return: -12.7%
  • 2-Year Price Return: -49.1%
  • 5-Year Price Return: 39.1%

Visit the Passiv Stock Directory

Data provided by IEX Cloud

For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast